in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Watson Pharmaceuticals to Acquire Actavis for $5.6 Billion
3:03 AM MDT | April 26, 2012 | Deepti Ramesh
Watson Pharmaceuticals (Parsippany, NJ), a leading manufacturer of generic, branded and biologic pharmaceutical products, and privately held generic pharmaceuticals company Actavis (Zug, Switzerland) say that Watson has entered into a definitive agreement to acquire Actavis for €4.25 billion ($5.6 billion). The announcement of the acquisition confirms an earlier report. Watson expects the transaction to close in the fourth quarter of 2012. Following the acquisition, Watson will become the third largest generics company in the world with 2012 anticipated pro...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee